RadSite issues breast CBCT coverage guideline

RadSite has published a new clinical coverage guideline for breast cone beam CT, setting criteria for when the compression-free 3D imaging tool may be medically necessary. The framework also addresses MRI alternatives, evidence review and CPT coding as breast imaging providers and payers assess coverage decisions.

Why it matters: - The guideline could help clinicians, imaging centers and payers decide when Breast CBCT is appropriate for diagnosis, treatment planning and medical necessity reviews. - RadSite is positioning Breast CBCT as a practical option for patients who need 3D breast imaging but cannot undergo MRI. - The framework may influence how advanced breast imaging is evaluated for coverage and reimbursement.

What happened: - RadSite published a new Clinical Coverage Guideline for Breast Cone Beam Computed Tomography, or Breast CBCT. - The guideline was developed with input from industry experts and reviewed by RadSite’s CBCT Standards Committee. - The framework is informed by clinical evidence and technical information from Koning. - RadSite said the guideline establishes criteria for appropriate clinical use and medical necessity. - RadSite also hosted a complimentary webinar in June titled “Breast Cone Beam CT: Emerging Clinical Applications and the Development of Guidelines.”

The details: - Breast CBCT creates three-dimensional breast images while the patient is positioned prone and without breast compression. - The guideline says Breast CBCT may be appropriate for diagnostic or treatment-planning use when mammography or ultrasound is inconclusive or technically limited. - The guideline identifies Breast CBCT as a potential alternative for patients who cannot undergo breast MRI because of severe claustrophobia, a contraindication to gadolinium-based contrast agents, or MRI-incompatible implanted devices. - A 2024 meta-analysis cited in the guideline found contrast-enhanced Breast CBCT had pooled sensitivity of 92%, compared with 77% for standard mammography, with similar specificity. - The guideline summarizes Category III CPT codes used to report unilateral and bilateral Breast CBCT studies. - Those codes identify the services but do not guarantee coverage or reimbursement. - Individual copies of the guideline are available for non-commercial download via the publication download.

Between the lines: - RadSite is trying to move Breast CBCT from an emerging technology toward a more standardized coverage pathway. - The emphasis on MRI substitution signals a focus on patients with access or tolerance barriers, not just diagnostic performance. - The guideline also reinforces that coding alone does not determine payment, so payer policies will still shape adoption. - RadSite said facilities offering Breast CBCT should also consider accreditation, which evaluates technical proficiency, documentation and dose management protocols.

What's next: - Clinicians and imaging facilities can use the guideline when deciding whether Breast CBCT fits a patient’s workup. - Payers and utilization management teams may use the framework as a reference for coverage decisions. - RadSite says Breast CBCT facilities should consider accreditation as they expand use of the technology. - More information is available at RadSite.